Results 131 to 140 of about 62,270 (271)

Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies. [PDF]

, 2019
BackgroundSmoking is a major risk factor for COPD and may impact the efficacy of COPD treatments; however, a large proportion of COPD patients continue to smoke following diagnosis.MethodsThis post-hoc analysis of pooled data from the replicate 12-week ...
Bowling, Alyssa, Goodin, Thomas, Ozol-Godfrey, Ayca, Price, Barry, Sanjar, Shahin, Sharma, Sanjay, Tashkin, Donald P   +6 more
core   +1 more source

Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry

Allergy, EarlyView.
Stéphanie Wanin, Rola Abou Taam, Lisa Giovannini Chami, Christophe Marguet, Jocelyne Just, Christele Da Silva, Jérôme Msihid, Olivier Ledanois, Rebecca Gall, Harry J. Sacks, Juby A. Jacob‐Nara, Capucine Daridon, Antoine Deschildre   +12 more
wiley   +1 more source

Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma

, 2002
Felix SF Ram, D. Brocklebank, John White, John Wright, Paul Jones   +4 more
openalex   +2 more sources

Bronchodilator treatment and deaths from asthma: case-control study [PDF]

, 2004
H R Anderson, Jon G. Ayres, P. Sturdy, J Martin Bland, Barbara K. Butland, Clare Peckitt, Jennifer Taylor, Christina Victor   +7 more
openalex   +1 more source

IMPROVED DETECTION OF BRONCHODILATATION FROM AEROSOLIZED BRONCHODILATORS [PDF]

, 2007
James E. Hansen, Xing‐Guo Sun, Karlman Wasserman   +2 more
openalex   +1 more source

Trajectory‐Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069

Allergy, EarlyView.
Khezia Asamoah, Freda Yang, Ian M. Adcock, Dragana Vuckovic, Mohib Uddin, Kian Fan Chung, Marc Chadeau‐Hyam   +6 more
wiley   +1 more source

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies

International Journal of COPD, 2019
Jill A Ohar,1 Alyssa Bowling,2 Thomas Goodin,2 Barry Price,2 Ayca Ozol-Godfrey,2 Sanjay Sharma,2 Shahin Sanjar2 1Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Sunovion Pharmaceuticals Inc, Marlborough, MA, USA
Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S   +6 more
doaj  

Respiratory impedance in healthy subjects: baseline values and bronchodilator response [PDF]

, 2013
Ellie Oostveen, Krisztina Boda, C.P.M. van der Grinten, Anthony James, Sally Young, Hans Nieland, Zoltán Hantos   +6 more
openalex   +1 more source

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

International Journal of COPD, 2018
Colin Reisner,1,2 James Pearle,3 Edward M Kerwin,4 Earl St Rose,1 Patrick Darken1 1Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA; 2AstraZeneca, Gaithersburg, MD, USA; 3California Research Medical Group, Inc., Fullerton, CA, USA ...
Reisner C, Pearle J, Kerwin EM, St Rose E, Darken P   +4 more
doaj  

The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPD [PDF]

, 2021
William W. Stringer, János Pórszász, Min Cao, Harry B. Rossiter, Shahid Siddiqui, Stephen I. Rennard, Richard Casaburi   +6 more
openalex   +1 more source